Megestrol: Difference between revisions
Jump to navigation
Jump to search
m Protected "Megestrol": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
Line 1: | Line 1: | ||
{{drugbox | {{drugbox |
Revision as of 17:17, 9 August 2012
Clinical data | |
---|---|
Pregnancy category |
|
ATC code | |
Pharmacokinetic data | |
Elimination half-life | 34 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C22H30O3 |
Molar mass | 342.472 g/mol |
For patient information, click here.
Megestrol is a progesterone derivative with antineoplastic properties used in the treatment of advanced carcinoma of the breast and endometrium. When given in relatively high doses, Megestrol can substantially increase appetite in most individuals, even those with advanced cancer.
Megestrol Acetate Oral Suspension (a form of Megestrol) is used primarily as an appetite enhancer. The method of appetite enhancement is not known, but it CAN cause hyperglycemia also known as high blood sugar[ http://www.megacees.com/megacees-side-effects.html].
Currently, it is manufactured under the trade name Megace [1]
Categories:
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Progestagens